Analystreport

Integra Lifesciences Holdings Corp (NASDAQ: IART) was upgraded by analysts at BTIG Research from a "neutral" rating to a "buy" rating. They now have a $69.00 price target on the stock.

Integra LifeSciences Holdings Corporation  (IART) 
Last integra lifesciences holdings corporation earnings: 2/19 06:00 am Check Earnings Report
US:NASDAQ Investor Relations: investor.integralife.com